Feng Shixing, Wang Tianyi, Su Yang, Yan Jinlong, Wang Yiheng, Zhang Zhenqiang, Yin Chaohui, Zhai Huaqiang
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100026, China; Institut International de Médecine Intégrative, Centre France Chine de la Médecine Chinoise, Selles sur Cher 41130, France.
Institut International de Médecine Intégrative, Centre France Chine de la Médecine Chinoise, Selles sur Cher 41130, France.
Ageing Res Rev. 2025 Feb;104:102644. doi: 10.1016/j.arr.2024.102644. Epub 2024 Dec 17.
Despite increasing global awareness of dementia, reliable estimates of the disease burden associated with Early-Onset Dementia (EOD) remain insufficiently quantified. This study aims to estimate the disease burden of EOD, analyze the burden attributable to risk factors from 1990 to 2021, and project these trends to 2050 at global, regional, and national levels, providing essential data to inform public health policy.
By utilising data from the GBD 2021 database, this study analysed metrics such as age-standardized prevalence (ASPR), mortality (ASMR), and disability-adjusted life years (AS-DALYs) for EOD. Joinpoint Regression analysis was used to calculated average annual percent changes (AAPCs) of ASPR, ASMR, and AS-DALYs. Then, the disease burden attributable to high fasting plasma glucose (FPG), high body-mass index (BMI), and tobacco were also reported. Finally, the Bayesian age-period-cohort (BAPC) model was employed to project global ASPR, ASMR and AS-DALYs, as well as ASMR and AS-DALYs attributed to the three risk factors from 2022 to 2050.
In 2021, the global case numbers of prevalence, mortality and DALYs for EOD were 7.75 (95 %UI: 5.82, 10.08) million, 73,386 (14,059, 232,169), and 3.77 (1.69, 8.88) million. Despite large increases in case numbers, AAPCs of ASR (0.08 % [0.02, 0.14], 0.07 % [0.05, 0.1], and 0.08 % [0.05, 0.1]) kept stable. Females exhibited higher case numbers and ASR across all disease burden indicators than males. Region- and country-level geographical heterogeneities were evident. Furthermore, global ASMR and AS-DALYs associated with high BMI and high FPG showed a steady increase, while the growth in ASMR and AS-DALYs attributable to tobacco has declined. To 2050, global case numbers of prevalence, mortality and DALYs for EOD will continue to rise, but ASRs won't change considerably. Females are anticipated to remain at a higher risk. The disease burden associated with high BMI and high FPG are expected to persist in their upward trends, whereas that related to tobacco are projected to decline.
The increasing burden of EOD underscores the critical need for tailored public health strategies and policies, a unique challenge underrecognized before.
尽管全球对痴呆症的认识不断提高,但与早发性痴呆症(EOD)相关的疾病负担的可靠估计仍未得到充分量化。本研究旨在估计EOD的疾病负担,分析1990年至2021年风险因素所致的负担,并在全球、区域和国家层面将这些趋势预测至2050年,为公共卫生政策提供重要数据。
本研究利用全球疾病负担研究(GBD)2021数据库的数据,分析了EOD的年龄标准化患病率(ASPR)、死亡率(ASMR)和伤残调整生命年(AS-DALYs)等指标。采用Joinpoint回归分析计算ASPR、ASMR和AS-DALYs的平均年度百分比变化(AAPCs)。然后,还报告了高空腹血糖(FPG)、高体重指数(BMI)和烟草所致的疾病负担。最后,采用贝叶斯年龄-时期-队列(BAPC)模型预测2022年至2050年全球ASPR、ASMR和AS-DALYs,以及这三种风险因素所致的ASMR和AS-DALYs。
2021年,全球EOD的患病率、死亡率和伤残调整生命年病例数分别为775万(95%UI:582万,1008万)、73386例(14059例,232169例)和377万例(169万例,888万例)。尽管病例数大幅增加,但ASR的AAPCs保持稳定(分别为0.08%[0.02%,0.14%]、0.07%[0.05%,0.1%]和0.08%[0.05%,0.1%])。在所有疾病负担指标上,女性的病例数和ASR均高于男性。区域和国家层面存在明显的地理异质性。此外,全球与高BMI和高FPG相关的ASMR和AS-DALYs呈稳步上升趋势,而烟草所致的ASMR和AS-DALYs增长有所下降。到2050年,全球EOD的患病率、死亡率和伤残调整生命年病例数将继续上升,但ASR不会有显著变化。预计女性仍将面临更高风险。与高BMI和高FPG相关的疾病负担预计将持续上升趋势,而与烟草相关的疾病负担预计将下降。
EOD负担的增加凸显了制定针对性公共卫生战略和政策的迫切需求,这是此前未得到充分认识的独特挑战。